e-learning
resources
Stockholm 2007
Monday 17.09.2007
Environmental and clinical aspects of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of COPD: updated meta-analysis results
R. Halbert, J. Natoli, A. Gano, D. Mannino, S. Buist (Los Angeles, CA, Beverly Hills, CA, Lexington, KY, Portland, OR, United States Of America)
Source:
Annual Congress 2007 - Environmental and clinical aspects of COPD
Session:
Environmental and clinical aspects of COPD
Session type:
Electronic Poster Discussion
Number:
1912
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Halbert, J. Natoli, A. Gano, D. Mannino, S. Buist (Los Angeles, CA, Beverly Hills, CA, Lexington, KY, Portland, OR, United States Of America). Prevalence of COPD: updated meta-analysis results. Eur Respir J 2007; 30: Suppl. 51, 1912
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prevalence of COPD by severity level: systematic review and meta-analysis
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007
Risk of pneumonia related to budesonide use in COPD: An updated pooled analysis
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012
COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Pulmonary hypertension in COPD patients: a systematic review and meta-analysis
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019
Worldwide under-diagnosis of COPD: results from the bold study
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009
GOLD classification of COPD and subsequent mortality: findings from a cohort study
Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment
Year: 2004
The global epidemiology of chronic cough in adults: a systematic review and meta-analysis
Source: Eur Respir J 2015; 45: 1479-1481
Year: 2015
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Characteristics of COPD patients with repeated exacerbations: preliminary results from the PRE-SPIRO survey
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
Prevalence of undiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007
Blood eosinophilia as predictor for outcomes in COPD exacerbations: a systematic review and meta-analysis
Source: International Congress 2017 – Management of COPD
Year: 2017
Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Efficacy of pharmacotherapy for OSA in adults: a systematic review and network meta-analysis
Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Year: 2019
Prediction models for the development of COPD: a systematic review
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Sarcopenia in COPD: a systematic review and meta-analysis
Source: Eur Respir Rev, 28 (154) 190049; 10.1183/16000617.0049-2019
Year: 2019
The prevalence and related factors of fatigue in patients with COPD: a systematic review
Source: Eur Respir Rev, 30 (160) 200298; 10.1183/16000617.0298-2020
Year: 2021
The cost of COPD: results from the SIRIBO study
Source: Eur Respir J 2002; 20: Suppl. 38, 125s
Year: 2002
FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts
Source: Eur Respir J 2013; 42: 1391-1401
Year: 2013
Job strain and COPD exacerbations: an individual-participant meta-analysis
Source: Eur Respir J 2014; 44: 247-251
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept